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Aim: To study the relationship between respiratory/allergic disorders and chronic
environmental tobacco smoke (ETS) exposure to husband or at workplace among non-
smoking women of a general population in Italy.
Methods: Analyses regard 2195 married or employed women. Information was collected
through a self-administered questionnaire. ETS exposure was validated by salivary
cotinine.
Results: Exposure both to husband and at work resulted a significant risk factor for
current dyspnoea (odds ratio (OR) 1.61, 95% confidence interval (CI) 1.20–2.16), any
shortness of breath at rest (OR 2.81, 95% CI 1.83–4.30), recent wheeze (OR 1.71, 95% CI
1.04–2.82), recent attacks of shortness of breath with wheeze (OR 1.85, 95% CI 1.05–3.26),
asthma diagnosis/symptoms (OR 1.50, 95% CI 1.09–2.08), diagnosis of asthma or
bronchitis/emphysema (obstructive lung diseases (OLD)) (OR 2.24, 95% CI 1.40–3.58),
current cough/phlegm (OR 1.52, 95% CI 1.07–2.15), and rhino-conjunctivitis (OR 1.48, 95%
CI 1.13–1.94). Exposure only at work yielded higher adjusted odds ratios for all health
conditions, except for rhino-conjunctivitis. Overall, about 24% of shortness of breath at
rest, 16% of dyspnoea, 17% of rhino-conjunctivitis, 12% of OLD, and 10% of asthma
diagnosis/symptoms are attributable to the effect of exposures to both husband and at
work. Twelve percent of shortness of breath at rest and 10% of rhino-conjunctivitis cases
might be avoided by eliminating exposure only at work and only to husband, respectively.Elsevier Ltd. All rights reserved.
502031/913632; fax: +39 050 503596.
. Viegi).
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M. Simoni et al.532Conclusions: Lifetime ETS exposure, especially at work, is associated with respiratory
symptoms/diseases, and it accounts for a sizeable proportion of such disorders. The
combined effect of both exposures is higher than the separate effects.
& 2006 Elsevier Ltd. All rights reserved.Introduction
Environmental tobacco smoke (ETS) is a common indoor
pollutant originated by tobacco combustion.1 Respiratory
health effects of involuntary smoking among children/
adolescents are well documented. Coherent epidemiological
data suggest that ETS exposure makes an important
contribution to childhood asthma. Moreover, ETS exposure
worsens the severity of asthma symptoms.2,3
Several studies indicate that ETS exposure is associated
with an increased risk of cardiac diseases and lung cancer in
adults.4–7 Associations between self-reported ETS exposure
and obstructive lung diseases (OLD), including asthma and
chronic bronchitis/emphysema, were also found.8,9
Women seem to be at higher risk of ETS exposure than
men. In California, median time of ETS exposure among
exposed subjects was found to be longer in women than in
men, mainly at home and in small spaces, including
offices.10 The FinEsS Study showed that in Estonia, ETS
exposure at home was 1.6 fold more common in females
than in males.11
Studies indicating evidence of a causal relation for
chronic respiratory symptoms in adults were reviewed by
Jaakkola et al.1,12 However, few studies presented data
stratified by gender.
Aim of our work is to investigate the relationship between
respiratory disorders and lifetime chronic ETS exposure to
husband or at workplace in never smoker women from
general population samples in Italy.Methods
The SEASD study (Italian acronym for ‘‘Studio Epidemiolo-
gico su Ambiente e Salute nelle Donne’’) was conducted in
four areas characterized by different economic backgrounds
and urbanization levels: the Po River Delta (a rural area in
North-Italy), Pisa (a historic, middle-sized town in Tuscany,
Central Italy), Viterbo (a small town including the nearby
rural area in Lazio, Central Italy), and the metropolitan area
of Rome (Central Italy).13,14
The study involved 2335 self-reporting never-smoking
women (13–97 yr old), selected from the general population
of participants in the second cross-sectional surveys of the
prospective studies in Po River Delta (n ¼ 1499) and Pisa
(n ¼ 1553),15,16 and from the mothers of the children living
in Viterbo (n ¼ 586) and Rome (n ¼ 1261), who already
participated in a population-based study on asthma pre-
valence (SIDRIA Study),17,18 Italian part of the ISAAC Study.19
The details of the study and the selection procedures have
been reported elsewhere.14 Briefly, 3330 eligible women
were invited (by mail and, subsequently, by phone) to fill out
self-administed questionnaires for participating in a survey
on health status and environmental factors, with no mentionof the specific aim regarding ETS exposure. The question-
naires were sent by mail or hand delivered at home. The
response rate was 77% (n ¼ 2552). A check of the smoking
status indicated that 217 women had started smoking since
the previous surveys. Thus, 2335 women were selected for
the study.
The research protocol was approved by the Ethical
Committee of the Catholic University in Rome, and informed
consent was obtained from each subject.
Respiratory symptoms/diseases
We evaluated the effects of ETS exposure on: (1) current
dyspnoea on exertion; (2) any shortness of breath at rest; (3)
recent wheeze; (4) recent shortness of breath with wheeze;
(5) asthma diagnosis/symptoms; (6) any OLD; (7) current
cough/phlegm; (8) any rhino-conjunctivitis. The presence of
symptoms/diseases was evaluated on the basis of the
answers to the questions reported in the Appendix.
Exposure assessment
To assess chronic lifetime ETS exposure, we considered the
answers to the following questions:(a) ‘‘Have you ever been exposed to smoke from your
husband/partner?’’ (any exposure to husband);(b) ‘‘Have you ever been exposed to smoke at workplace?’’
(any exposure at workplace).In order to compare the effects of exposures to different
ETS sources, women were classified into the following
categories: (1) never exposed, when they reported to have
been never exposed to husband/partner nor at workplace;
(2) exposed only at work; (3) exposed only to husband; (5)
exposed to both, when women reported lifetime ETS
exposure both to husband and at workplace.
Cotinine measurements in saliva were available for a sub
sample of 1379 women (63%), who participated in a physical
examination,14 thus allowing to confirm self-reported non-
smoking status.
Salivary cotinine levels were measured with the radio-
immunoassay (RIA) described by Van Vunakis et al.20 The
limit of detection was 0.2 ng/mL. Smoking status was
assessed by using the suggested thresholds for discriminating
active smokers from non smokers (106 ng/mL).21
Statistical analyses
Statistical analyses were performed with the Statistical
Package for the Social Sciences (SPSS/PC, 2000). Used
routines were: frequency distributions, w2-test, and logistic
regression analysis.
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Table 1 General characteristics of the sample
(n ¼ 2195).
n %
Area of residence
Northern rural (Po River Delta) 518 23.6
Northern-central urban (Pisa) 561 25.6
Central metropolitan (Rome) 760 34.6
Central urban-rural (Viterbo) 356 16.2
School level (yrs)
o6 719 32.8
6–8 532 24.3
9–13 702 32.1
413 236 10.8
Lifetime ETS exposure to husband or at work
Never 585 26.7
Only at work 335 15.3
Only to husband 808 36.8
To both 467 21.3
Symptoms/diseases
Current dyspnea 589 26.9
Any shortness of breath at rest 235 10.8
Recent wheeze 148 6.8
Recent attacks of shortness of
breath with wheeze
108 4.9
Asthma diagnosis/symptoms 405 18.7
Any OLD (diagnosis of asthma or 165 7.5
Health effects of passive smoking among never smoker women 533Never married and never employed women (n ¼ 92, 3.9%)
and those without complete information on either ETS
exposure (n ¼ 48, 2.0%) were excluded. Thus, 2195 married
or employed women (mean age 47 yrs, SD 14, median 44)
with valide answers to ETS exposure were retained for
statistical analyses.
The associations between each health condition and
lifetime ETS exposure were assessed by logistic regression
models with exposure as independent variable (reference
category ¼ never exposed), accounting for the effect of
age, place of residence, age-residence interaction, school
level attained (four levels of educational status: o6 yrs,
6–8, 9–13, 413).
Stratified logistic regression analyses for current/past
married (positive answer to the question ‘‘Have you ever
been married?’’, n ¼ 2040) or current/past working women
(positive answer to the question ‘‘Have you ever worked?’’
n ¼ 1245) women, were performed with ‘‘any’’ exposure as
independent risk factor, accounting for age, residence, age-
residence interaction, school level attained, and for any
exposure at work or from husband, respectively.
For significant associations, Population Attributable Risk
(PAR) was computed to estimate the number of cases with
disease or condition which would be avoided by eliminating
the exposure to the specific risk factor:
PAR ¼ 100 pðRR 1Þ=pðRR 1Þ þ 1,
where p is the proportion of population exposed and RR the
relative risk for exposed versus unexposed.22chronic bronchitis/emphysema)
Current cough/phlegm 354 16.2
Any rhino-conjunctivitis 799 36.6Results
Table 1 shows general characteristics of the sample. About
73% of the women reported lifetime ETS exposure to
husband or at work. Any exposure to husband was
significantly more prevalent than any exposure at work
(58% versus 36%, Po0:001). Only 11% of women had a
university degree. Current dyspnoea and any rhino-con-
junctivitis were the most frequently reported health out-
comes. The percentage of missing values regarding
symptoms/diseases and educational status ranged from
0.2% to 1.2%.
Table 2 shows the prevalence of ETS exposure by area of
residence, age groups, and education. The lowest preva-
lence of lifetime ETS exposure was in Po Delta area (56%),
while the highest was in Rome (82%). The prevalence of
exposure was the lowest (40%) in the youngest women, then
it increased in those aged 19–40 yr (69%), showing a peak in
those 41–65-yr-old (78%), and, at last, it decreased in the
elderly (68%). As regards the exposure to husband, the
exposed women resulted less educated than the unexposed
ones, in so far as there was a decreasing trend of exposure
with increasing educational level (67%, 63%, 59%, 56% for
o6 yr, 6–8, 9–13, 413, respectively). On the opposite, the
prevalence of exposure at work generally tended to increase
with increasing educational level (23%, 40%, 61%, 49%,
respectively). When exposure either to husband or at work
was considered, exposed women resulted more educated
than unexposed ones (prevalence of exposure 69%, 72%,
78%, 75% in the four educational levels, respectively).All the women who participated in the physical examina-
tion had salivary cotinine below the cut-off level proposed
by the Environmental Protection Agency (106 ng/mL) for
discriminating active smokers from non-smokers. Mean
cotinine level was lower in the women who reported never
exposure (n ¼ 372, 0.99 ng/mL, SD 2.0) than in those
reporting exposure only from husband (n ¼ 496, 1.2 ng/ml,
SD 2.3), only at work (n ¼ 208, 1.5 ng/mL, SD 3.5 ) or to both
sources (n ¼ 287, 1.8 ng/mL, SD 3.7).
Among current/past married women (n ¼ 2040), after
accounting for age, residence, education, age-residence
interaction, and exposure at work, any ETS exposure to
husband was associated with each health condition, sig-
nificantly for shortness of breath at rest (OR 1.41, 95% CI
1.03–1.93), OLD (OR 1.43, 95% CI 1.00–2.07), cough/phlegm
(OR 1.29, 95% CI 1.00–1.66), and rhino-conjunctivitis (OR
1.29, 95% CI 1.06–1.57) (Fig. 1).
Among working women (n ¼ 1245), after accounting for
age, residence, education, age–residence interaction, and
for exposure to husband, any ETS exposure at work was
associated with each symptom/disease, significantly for
dyspnoea (OR 1.58, 95% CI 1.15–2.17), shortness of breath at
rest (1.73, 1.13–2.64), wheeze (1.91, 1.03–3.52), asthma
diagnosis/symptoms (OR 1.53, 95% CI 1.08–2.18), and OLD
(OR 1.89, 95% CI 1.13–3.16) (Fig. 2).
When we compared the effects of the different sources
among married or employed women (n ¼ 2195) (Table 3),
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Table 2 Prevalence of ETS exposure by area of residence, age, and education.
Area of residence: Po River Delta Pisa Rome Viterbo P
Exposure
Never 227 (43.8) 142 (25.3) 135 (17.8) 81 (22.8)
Only at work 62 (12.0) 68 (12.1) 160 (21.1) 45 (12.6)
Only from Husband 164 (31.7) 272 (48.5) 209 (27.5) 163 (45.8)
Both 65 (12.5) 79 (14.1) 256 (33.7) 67 (18.8)
o0.001
Age group (yrs) p18 19–40 41–65 465
Exposure
Never 3 (60.0) 255 (30.8) 234 (22.0) 93 (31.2)
Only at work 1 (20.0) 195 (23.6) 133 (12.5) 6 (2.0)
Only from Husband — 216 (26.1) 420 (39.4) 172 (57.7)
Both 1 (20.0) 161 (19.5) 278 (26.1) 27 (9.1)
o0.001
School level (yrs) o6 6–8 9–13 413
Exposure
Never 220 (30.6) 147 (27.6) 158 (22.5) 58 (24.6)
Only at work 25 (3.5) 71 (13.3) 179 (25.5) 59 (25.0)
Only from Husband 379 (52.7) 200 (37.6) 161 (22.9) 67 (28.4)
Both 95 (13.2) 114 (21.4) 204 (29.1) 52 (22.0)
o0.001
P of the trends by w2.
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Figure 1 Association of health outcomes with ETS exposure to husband among married women, accounted for age, residence area,
education, age–area interaction, and ETS exposure at work.
M. Simoni et al.534the combined exposure both to husband and at work was a
significant risk factor for each health outcome. ORs ranged
from 1.48 for any rhino-conjunctivitis to 2.81 for any
shortness of breath at rest. The exposure only at work
tended to yield higher adjusted ORs for each symptom/
disease than exposure only to husband, except for rhino-
conjunctivitis. Estimated PAR% values indicate that about24% of shortness of breath at rest, 16% of dyspnoea, 17% of
rhino-conjunctivitis, 12% of OLD, 10% of asthma diagnosis/
symptoms, and 9% of cough/phlegm are attributable to the
combined effect of exposures both to husband and at work;
about 12% of shortness of breath at rest and 10% of rhino-
conjunctivitis might be avoided by eliminating exposure only
at work or only to husband, respectively (Table 2).
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Figure 2 Association of health outcomes with ETS exposure at workplace among working women, accounted for age, residence
area, education, age–area interaction, and ETS exposure to husband.
Health effects of passive smoking among never smoker women 535Discussion
This study involved a large number of never-smoking
females of a general population with a wide age span, and
with validation of the non-smoking status by cotinine levels.
It is adding information on poorly investigated respiratory
effects of ETS lifetime chronic exposure in women.
The prevalence of exposure to husband (58%) was similar
to those reported in some Chinese studies (51–60%),5,23,24
while the prevalence of exposure at work (36%) was
intermediate between those found in China (26%) and in
Switzerland (52%).24,25
To compare our results to other authors’ finding is not
easy. Most studies on ETS exposure involved children.
Surveys on health effects by spousal smoking among women
who never had been smoker primarily concern lung cancer
or heart diseases.4–6 Studies on adults only rarely report
results stratified for gender and they more likely concern
current exposure.11,26 Moreover, the effects of ETS at home,
rather than from husband, have been more often stu-
died.8,10,27 At this regard, for comparison with other
authors, we considered the exposure to husband as a proxy
of exposure at home, in so far as other lifetime exposures at
home did not change the results, once considered in the
regression models.
Our results confirm ETS exposure to be a risk factor for
respiratory health in women, especially when the subjects
were exposed both to husband and at work.
The significant association of dyspnoea with exposure to
both sources is in accordance with Leuenberger et al.,25 who
found dyspnoea related to home/work exposure (OR 1.43,
95% CI 1.18–1.74) in the Sapaldia study. The exposure at
work yielded a higher risk for dyspnoea and shortness of
breath than the exposure to husband, as previously
reported.11,28 Differently, Jedrykowsky et al.29 found a
significantly increasing risk for dyspnoea in women exposed
at home (OR 2.23, 95% CI 1.45–3.44) in Poland. However,they studied only elderly women, likely more susceptible to
ETS exposure,30 and they did not consider the confounding
effects of possible current/past exposures at work.
The relationship between ETS and asthma in adults is still
under scrutiny. According to the review of Weiss et al., there
is some evidence that ETS exposure, especially at work,
contributes to both development and exacerbation of
asthma.31 As other authors,11,28 we found that asthma
diagnosis/symptoms, as well as recent wheeze, were
significantly associated with any exposure at work, whereas
there was no association with any exposure to husband.
Instead, Thorn et al. reported a significant association of
asthma/asthma-like symptoms with ETS exposure at home
(OR 1.7, 95% CI 1.0–2.8) in Sweden.27 It is to point out that
the Swedish survey did not account for the possible
confounding effect of working exposure. Furthermore, in
our study recent wheeze resulted significantly associated
with exposure both to husband and at work, confirming the
relationship between wheeze and exposure at home/work
found in the Sapaldia study (OR 1.94, 95% CI 1.39–2.70).25
Mannino et al.32 analyzing the data of the NHANES III
surveys in the USA, demonstrated an overlap of the three
OLD conditions (diagnosis of asthma, chronic bronchitis or
emphysema), which was confirmed in Italian general
population samples.33 It is to point out that among our
women OLD was the only condition significantly associated
with both any exposure at work and any exposure to
husband. Moreover, differently from other symptoms/
diseases, the sum of the ORs for the associations of OLD
with the single exposures was close to the OR for the
association of OLD with exposure to both sources, thus
indicating an additive effect of the two sources.
Cough/phlegm resulted significantly associated with any
exposure at home, unlike a recent study on Californian
adults.10 Furthermore, the significant relationship with the
exposure both to husband and at work confirms the results
of the Sapaldia study.25
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Table 3 Estimated odds ratios (OR) and 95% confidence intervals (95%CI) for the association between chronic ETS exposure
and respiratory symptoms/diseases (reference category ¼ never exposure).
Symptom/disease ETS n (%) Crude OR Adjusted OR Adjusted PAR%
exposure (95%CI) (95%CI) (95%CI)
Current dyspnoea Never 142 (24.3) 1.00 1.00
Only at work 68 (20.4) 0.80 (0.58–1.11) 1.15 (0.81–1.63) NA
Only to husband 228 (28.4) 1.24 ( 0.97–1.58) 0.95 (0.73–1.23) NA
To both 151 (32.3) 1.49 (1.14–1.95) 1.61 (1.20–2.16) 16.3 (6.0–27.1)
Any shortness of breath
at rest
Never 38 (6.5) 1.00 1.00
Only at work 41 (12.3) 2.01 (1.27–3.20) 2.11 (1.30–3.43) 11.8 (3.5–22.6)
Only to husband 78 (9.7) 1.54 (1.03–2.30) 1.41 (0.94–2.14) NA
To both 78 (16.8) 2.91 (1.93–4.37) 2.81 (1.83–4.30) 23.5 (12.4–35.9)
Recent wheeze Never 37 (6.3) 1.00 1.00
Only at work 19 (5.7) 0.90 (0.51–1.59) 1.28 (0.70–2.35) NA
Only to husband 55 (6.8) 1.09 (0.71–1.68) 1.16 (0.74–1.81) NA
To both 37 (7.9) 1.28 (0.80–2.05) 1.71 (1.04–2.82) 5.4 (0.3–12.7)
Recent attacks of
shortness of breath with
wheeze
Never 25 (4.3) 1.00 1.00
Only at work 12 (3.6) 0.84 (0.42–1.70) 0.99 (0.48–2.07) NA
Only to husband 39 (4.9) 1.14 (0.68–1.91) 1.12 (0.66–1.89) NA
To both 32 (6.9) 1.65 (0.96–2.82) 1.85 (1.05–3.26) 5.6 (0.4–13.7)
Asthma diagnosis/
symptoms
Never 102 (17.6) 1.00 1.00
Only at work 60 (18.1) 1.04 (0.73–1.48) 1.20 (0.83–1.75) NA
Only to husband 137 (17.2) 0.97 (0.73–1.29) 0.94 (0.70–1.25) NA
To both 106 (23.0) 1.40 (1.03–1.90) 1.50 (1.09–2.08) 10.3 (2.0–19.9)
Any OLD Never 34 (5.8) 1.00 1.00
Only at work 22 (6.6) 1.14 (0.65–1.98) 1.29 (0.72–2.30) NA
Only to husband 56 (7.0) 1.21 (0.78–1.88) 1.09 (0.69–1.72) NA
To both 53 (11.4) 2.07 (1.32–3.25) 2.24 (1.40–3.58) 12.0 (4.2–22.1)
Current Never 80 (13.7) 1.00 1.00
cough/phlegm Only at work 53 (16.0) 1.20 (0.82–1.75) 1.32 (0.89–1.97) NA
Only to husband 135 (16.8) 1.27 (0.94–1.71) 1.31 (0.96–1.78) NA
To both 86 (18.5) 1.43 (1.03–2.00) 1.52 (1.07–2.15) 8.8 (1.3–17.9)
Any rhino-conjunctivitis Never 178 (30.6) 1.00 1.00
Only at work 134 (40.1) 1.52 (1.15–2.01) 1.18 (0.88–1.58) NA
Only to husband 285 (35.4) 1.24 (0.99–1.56) 1.30 (1.02–1.65) 9.5 (0.7–18.5)
To both 202 (43.4) 1.74 (1.35–2.24) 1.48 (1.13–1.94) 17.1 (5.3–28.8)
PAR ¼ population attributable risk; NA ¼ not attributable.
For age, educational, residence, age–residence interaction.
M. Simoni et al.536There is limited evidence about the relationship between
passive smoking and rhinitis in adults. According to
Benninger’s review, ETS exposure is associated with acute
and chronic nasal symptoms in adults.34 However, some
studies reported no association.25,28 Other authors showed
associations more evident with work than home exposure: in
pregnant Japanese women, the significant relation of
allergic rhinitis with exposure was stronger for work (OR
2.50, 95% CI 1.29–4.76) than for home exposure (OR 1.89,
95% CI 1.10–3.30).35 In our study we found a higher risk forhaving rhino-conjunctivitis among women exposed both to
husband and at work, and a significant correlation also with
the exposure only to husband.
In a previous study on this population of women, we found
ETS exposure to husband to be associated with a low socio-
economic status (SES), and this may be related to higher
prevalence of symptoms/diseases, thus indicating a possible
confounding effect by SES on the relation between ETS and
respiratory health.14 We adjusted for women’ educational
level but residual confounding might remain. However, in a
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Health effects of passive smoking among never smoker women 537sensitivity analysis (data not shown) the results did not
change when we also accounted for educational status of
husband, used as a proxy of SES.
Our results regarding a stronger effect of ‘‘combined’’
exposures deserve consideration. Our main explanation is
that the group exposed both at work and at home have
received a larger ETS exposure than those with only one
exposure: duration of work exposure in women exposed to
both sources was higher (11.9 years) than among those
exposed only at work (8.9 years, Po0:001); similarly the
lifetime number of exposure hours from husband, in women
with ‘‘combined’’ exposure, was higher than in those exposed
only from husband (21316h versus 20699h, Po0:05).
We have estimated that a sizeable proportion of any
shortness of breath at rest (24%), any rhino-conjunctivitis
(17%), current dyspnoea (16%), and asthma/bronchitis diag-
nosis (12%) might be abatable by eliminating the ‘‘combined’’
exposure from husband and at workplace. Unfortunately, we
found no information for comparison, in literature.
It is to point out that we assessed the effects of lifetime
chronic exposure, independently from the exposure timing.
Some exposures could occur only in the past, many years
previously. Thus, to use ‘‘any’’ lifetime exposure for
estimating the association with health might reduce the
risk associated with ETS exposure. However, analyses on the
association of symptoms/diseases with exposure ‘‘only in
the past’’, or ‘‘current’’, revealed the risk found for ‘‘any’’
exposure was consistent with the separate estimates.
With regard to potential self-reporting bias, we exclude
misunderstanding of the questions for the women who
participated in the physical examination (71%). In fact, for
them, the questionnaire was checked or completed in their
own presence by trained personnel in the day of examination.
A limitation of the study might be due to reporting bias of
exposure. As a general point in the interpretation of the
literature and of our findings, it is to mention that there
seems to be no indication about a possible influence of the
disease status on the self-reported exposure report.36 Life-
time exposure information can be collected only by ques-
tionnaires, and it cannot be objectively validated. However,
studies on indoor exposure assessment have found that the
subjects more generally tended to under-report rather than
over-report their exposure.37,38 At least with concern to non-
smoking status and recent exposure (in the last week), self-
report by the women of the SEASD was accurate, in so far as it
was coherent with measured cotinine levels.39
Conclusion
Lifetime ETS exposure, especially at work, was associated
with several respiratory symptoms/diseases. When the two
ETS exposures were considered together, they were linked to
larger health effects. The combined exposure accounted for a
sizeable proportion of such disorders, ranging from 5.4% for
recent wheeze to 23.5% for any shortness of breath at rest.
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Appendix A
Questions for estimating presence/absence of symptoms/
diseases:Symptom/disease QuestionCurrent dyspnoea on
exertion‘‘Have you got shortness of
breath when hurrying on level
ground or walking up a slight
hill?’’Any shortness of
breath at rest‘‘Have you ever perceived
shortness of breath at rest?’’Recent wheeze ‘‘Have you had wheezing or
whistling apart from common
colds in the last 12 months?’’Recent shortness of
breath with wheeze‘‘Have you had shortness of
breath with wheeze apart from
common colds in the in the last
12 months?’’Asthma diagnosis/
symptoms‘‘Have you ever had asthma
diagnosed by a physician?’’ or
‘‘Have you ever had wheezing?’’
or ‘‘Have you aver had shortness
of breath with wheeze apart
from common colds?’’Any OLD (obstructive
lung diseases)‘‘Have you ever had asthma
diagnosed by a physician?’’ or
‘‘Have you ever had chronic
bronchitis (or emphysema),
diagnosed by a physician?’’Current cough/phlegm ‘‘Have you got cough (or
phlegm) for at least 4 days a
week for at least 3 months a
year apart from common
colds?’’Any rhino-
conjunctivitis‘‘Have you ever had hay fever or
an allergic problem with a runny
or blocked nose when you did
not have a cold?’’ or ‘‘have you
ever had an allergic problem
with reddish, itchy, watery
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